Notice Title

Corrigendum—Consent to the Distribution of New Medicines

Publication Date
26 Mar 2019

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2019-go1373
Title
View PDF
File Type and Size
PDF (29 KB)

In the notice with the above heading, published in the New Zealand Gazette, 21 March 2019, Notice No. 2019-go1220, replace the entry for NYXOID with the following:

Schedule

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

NYXOID
Naloxone hydrochloride dihydrate 2.2mg equivalent to naloxone 1.8mg per 100mcL
Nasal spray solution
Mundipharma New Zealand Limited
Summit Biosciences LLC, Kentucky, United States of America

Dated this 25th day of March 2019.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).